Breast Cancer – Robert Figlin, MD, and Adam Brufsky, MD, PhD, discuss clinical highlights from SABCS 2020
ASH 2020 Advances Immunotherapies, Puts Spotlight on He...
Dec 14, 2020
By Mary Ellen Schneider
This year’s annual meeting of the American Society of Hematology (ASH) featured new research on chimeric antigen receptor (CAR) T-cel...
DAY 4: Circulating Tumor Cells, HDAC Inhibition, and Ne...
Dec 11, 2020
by Chase Doyle
Day 4 of the 2020 San Antonio Breast Cancer Symposium (SABCS) virtual meeting featured advances in early treatment monitoring, a surprising setb...
DAY 3: Less Chemo, Fewer Pregnancies, and a Setback for...
Dec 10, 2020
by Chase Doyle
Day 3 of the 2020 San Antonio Breast Cancer Symposium (SABCS) virtual meeting featured advances in how to optimally use adjuvant chemotherapy fo...
Stemming from the user preference that you set, stay informed and increase your productivity via 27/7 web based access to OntelligenceTM and a customized email alert system summarizing the most recent oncology-specific information available.
Learn MoreThe Oncology Business Dynamics Learning Platform addresses the need to have a high level of understanding of the non-clinical issues that are influencing the decision making process for hem/oncs today.
Learn More[Virtual Format]
[Virtual Format]
[Virtual Format]
[Virtual Format]
[Virtual Format]
[Virtual Format]
Vienna, Austria
[Virtual Format]
Geneva, Switzerland
[Virtual Format]
[Virtual Format]
San Francisco, CA
[In Person/Virtual - TBD]
Berlin, Germany
[Virtual Format]
Chicago, IL
[Virtual Format]
Barcelona, Spain
Philadelphia, PA
[Virtual Format]
Paris, France
Austin, TX
Chicago, IL
San Antonio, TX
Atlanta, GA (In-Person/Virtual)